In-person seminars will be held in:

 1-125 Cancer & Cardiovascular Research Building (CCRB)
 
____________________________________________________________________________________________________

February 2, 2026

"Vax-Innate: A Paradigm for Developing Tumor Vaccines to Induce Stem-like CD8 T cells and Modulate the Tumor Microenvironment"

Robert Seder, M.D.
Chief of the Cellular Immunology Section in the Vaccine Research Center, NIAID, NIH
Host: David Masopust
___________________________________

February 16, 2026

“Mechanisms of anti-cancer immunity elicited by natural microbial exposure”

Francesco Marangoni, Ph.D.
Assistant Professor, Physiology & Biophysics
School of Medicine, University of California, Irvine
Host: David Masopust
___________________________________

March 2, 2026

"Disease-associated T cells in the development of type 1 diabetes"

Maki Nakayama, M.D.
Associate Professor, University of Colorado, Anschutz Campus, School of Medicine, Barbara Davis Center for Diabetes Basic Research, 
Host: Brian Fife
___________________________________

March 16, 2026

"Thetis cell regulation of intestinal tolerance."

Chrysothemis Brown, M.D., Ph.D.
Assistant Attending Physician; Assistant Member, Memorial Sloan Kettering Cancer Center
Host: Ryan Nelson
___________________________________

March 30, 2026

"Adaptive immune responses in pulmonary fibrosis"

Anne Sperling, Ph.D.
Professor, Medicine and Pulmonary and Critical Care Medicine, University of Virginia
Host: Jesse Williams
___________________________________

April 13, 2026

"Defining the causes and consequences of T cell clonal expansion in the liver during chronic disease"  

Matthew Burchill, PhD
Associate Professor
University of Colorado Denver - Anschutz Medical Campus
Host: Mike Farrar
 _______________________________________

April 27, 2026

Title TBA

William (Bill) Hawse, Ph.D.
Assistant Professor, Department of Immunology, University of Pittsburgh
Host: Craig Byersdorfer
___________________________________